Indications and uses
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief is indicated for use as part of a professional program for the prevention and control of dental caries.
Acclean Anti-Cavity Sensitivity Relief
- Manufacturer
- Henry Schein, Inc. | Den-Mat Holdings, LLC
- Effective date
- 2024-11-14
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:26:13
Label at a glance#
ProductAcclean Anti-Cavity Sensitivity Relief
Active ingredientPOTASSIUM NITRATE, SODIUM FLUORIDE
Label structure16 sections
Dosage and administration
Follow these instructions or use as instructed by a dental professional. Adults and children age 12 or older, apply a thin ribbon or pea-sized amount of Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief to a toothbrush and brush thoroughly on all tooth surfaces for at least one minute. After use: Adults should expectorate. For best results, do not eat, drink, or rinse for 30 minutes. Chil...
Storage and handling
4 oz. (113.4g) net wt. tube Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief NDC 0404 0174 04 Store at controlled room temperature 15°-30° C (59°-86° F) Rx Only Distributed by: Henry Schein Inc. 135 Duryea Road Melville, NY 11747 USA 753212700 R:0 01/24SN
Label contents#
Full prescribing information#
HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief safely and effectively. See full prescribing information.
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief with 1.1% Sodium Fluoride, 5% Potassium Nitrate for oral use
INDICATIONS AND USAGE
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief is indicated for use as part of a professional program for the prevention and control of dental caries. (1)
DOSAGE AND ADMINISTRATION
- Apply a thin ribbon or pea-sized amount of Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief to a toothbrush and brush thoroughly on all tooth surfaces for at least one minute. (2)
- After use, adults should expectorate. For best results, do not eat, drink, or rinse for 30 minutes. Children, age 12-16, should expectorate after use and rinse mouth thoroughly. (2)
- Children under 12 years of age should consult a dentist or doctor.
- Use twice daily as your normal dentifrice or as directed by your dental professional. (2)
DOSAGE FORMS AND STRENGTHS
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief Mint Flavor: Green toothpaste containing 1.1% Sodium Fluoride, 5% Potassium Nitrate (Mint). (3)
CONTRAINDICATIONS
Do not use in children under 6 years of age unless recommended by a dentist or physician. (4)
WARNINGS AND PRECAUTIONS
- DO NOT SWALLOW. (5)
- Keep out of reach of children under 12 years of age. If more than used for brushing is accidentally swallowed, get medical help or contact a Poison Control Center right away. (5)
- Repeated ingestion of high levels of fluoride may cause dental fluorosis. (5)
- Do not use this product longer than 4 weeks unless recommended by a dentist or physician. (5)
ADVERSE REACTIONS
Allergic reactions and other idiosyncrasies have rarely been reported. (6)
To report SUSPECTED ADVERSE REACTIONS, contact your Henry Schein Dental representative.
FULL PRESCRIBING INFORMATION: CONTENTS*
1 INDICATIONS AND USAGE
2 DOSAGE AND ADMINISTRATION
3 DOSAGE FORMS AND STRENGTHS
4 CONTRAINDICATIONS
5 WARNINGS AND PRECAUTIONS
6 ADVERSE REACTIONS
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
8.3 Nursing Mothers
8.4 Pediatric Use
8.5 Geriatric Use
10 OVERDOSAGE
11 DESCRIPTION
12 CLINICAL PHARMACOLOGY
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
15 REFERENCES
16 HOW SUPPLIED/STORAGE AND HANDLING
* Sections or subsections omitted from the full prescribing information are not listed.
1 INDICATIONS AND USAGE
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief is indicated for use as part of a professional program for the prevention and control of dental caries.
2 DOSAGE AND ADMINISTRATION
- Follow these instructions or use as instructed by a dental professional.
- Adults and children age 12 or older, apply a thin ribbon or pea-sized amount of Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief to a toothbrush and brush thoroughly on all tooth surfaces for at least one minute.
After use:
- Adults should expectorate. For best results, do not eat, drink, or rinse for 30 minutes.
- Children, age 12 to 16, should expectorate after use and rinse mouth thoroughly.
- Use twice daily as your normal dentifrice or as directed by your dental professional.
3 DOSAGE FORMS AND STRENGTHS
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief: Green toothpaste containing 1.1% Sodium Fluoride, 5% Potassium Nitrate (Mint). (3)
4 CONTRAINDICATIONS
Do not use in children under 12 years of age unless recommended by a dentist or physician.
5 WARNINGS AND PRECAUTIONS
DO NOT SWALLOW.
- Keep out of reach of children under 12 years of age. If more than used for brushing is accidentally swallowed, get medical help or contact a Poison Control Center right away.
- Prolonged daily ingestion may result in various degrees of dental fluorosis in children with developing dentition, especially if the water fluoridation exceeds 0.6 ppm, since younger children frequently cannot perform the brushing process without significant swallowing.
- Use in children under age 6 years requires special supervision to prevent repeated swallowing of toothpaste which could cause dental fluorosis.
- Read directions carefully before using.
- Keep out of reach of infants and children.
- Sensitive teeth may indicate a serious problem that may need prompt care by a dentist.
- See your dentist if the problem persists or worsens. Do not use this product longer than 4 weeks unless recommended by a dentist or physician.
6 ADVERSE REACTIONS
Allergic reactions and other idiosyncrasies have rarely been reported.
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Category B
It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. There are no adequate or well controlled clinical studies in pregnant women. However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childhood.
8.3 Nursing Mothers
It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.
8.4 Pediatric Use
The use of Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief in children age 6-16 as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11-14 years conducted by Englander, et al.2-4 Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water, and other sources) when prescribing the product for use in children. Please refer to the CONTRAINDICATIONS and WARNINGS AND PRECAUTIONS sections.
8.5 Geriatric Use
Subjects referenced in clinical studies of 1.1% (w/v) sodium fluoride, included 15 percent age 65 and over, with 1 percent age 75 and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger clients, but greater sensitivity of some older individuals cannot be ruled out. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in clients with impaired renal function. Because elderly clients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
10 OVERDOSAGE
Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) have been ingested, induce vomiting, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility.
11 DESCRIPTION
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief is a self-applied topical fluoride dentifrice containing 1.1% (w/w) sodium fluoride for the prevention and control of dental caries, and 5% (w/w) P otassium Nitrate for relief of tooth sensitivity.
Sensitivity Relief: Each gram contains 5 mg of fluoride ion in a neutral pH base, consisting of Cellulose Gum, D&C Yellow No. 10, FD&C Blue No. 1, Flavor, Glycerin, Mica (and) Titanium Dioxide, PEG/PPG-116/66 Copolymer, Potassium Nitrate, Silica, Sodium Lauryl Sulfate, Sodium Saccharin, Sorbitol, Water, Xylitol.
12 CLINICAL PHARMACOLOGY
A treatment dose (a thin ribbon) of Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief 5000 ppm sodium fluoride toothpaste contains 2.5 mg fluoride. A 4 oz. tube contains 566 mg fluoride.
Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer. Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results. Potential adverse reproductive effects of fluoride exposure in humans have not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.
15 REFERENCES
- American Dental Association, Council on Dental Therapeutics, Fluoride compounds, In: Accepted Dental Therapeutics, Ed. 40, Chicago, ADA, 405-407, (1984).
- Englander HR, et al., Clinical Anticaries Effect of Repeated Topical Sodium Fluroide Applications by Mouthpieces, JADA, 75, 638-644, (1967).
- Englander HR, et al., Residual Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces, JADA, 78, 783-787 (1969).
- Englander HR, et al: JADA, 83:354-358, 1971.
16 HOW SUPPLIED/STORAGE AND HANDLING
4 oz. (113.4g) net wt. tube
Acclean Prescription Strength Anti-Cavity Toothpaste for Sensitivity Relief NDC 0404 0174 04
Store at controlled room temperature 15°-30° C (59°-86° F)
Rx Only
Distributed by:
Henry Schein Inc.
135 Duryea Road
Melville, NY 11747 USA
753212700 R:0 01/24SN
Principal Display Panel – 113.4 g Carton Label
ACCLEAN™
PRESCRIPTION STRENGTH
ANTI-CAVITY
TOOTHPASTE
1.1 % Sodium Fluoride
5000 PPM
5% Potassium Nitrate
For
Sensitivity
Relief,
Mint
NET WT: 4 FL OZ (113.4g)
by HENRY SCHEIN®
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 637365 | potassium nitrate 5 % / sodium fluoride 1.1 % Toothpaste | PSN | 1 |
| 637365 | potassium nitrate 0.05 MG/MG / sodium fluoride 0.011 MG/MG Toothpaste | SCD | 1 |
| 637365 | K+ nitrate 0.05 MG/MG / Sodium Fluoride 0.011 MG/MG Toothpaste | SY | 1 |
| 637365 | Pot nitrate 0.05 MG/MG / Sodium Fluoride 0.011 MG/MG Toothpaste | SY | 1 |
| 637365 | potassium nitrate 5 % / sodium fluoride 1.1 % Gel Toothpaste | SY | 1 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0404-0174-04 | Acclean Anti-Cavity Sensitivity Relief | 113.4 g in 1 TUBE | PASTE, DENTIFRICE | 113.4 | 1 | |
| 0404-0174-04 | Acclean Anti-Cavity Sensitivity Relief | 1 in 1 CARTON | PASTE, DENTIFRICE | 1 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Acclean Anti-Cavity Sensitivity Relief
- POTASSIUM NITRATE, SODIUM FLUORIDE
- POTASSIUM NITRATE
- NITRATE ION
- SODIUM FLUORIDE
- FLUORIDE ION
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
- D&C YELLOW NO. 10
- FD&C BLUE NO. 1
- Glycerin
- Mica
- Titanium Dioxide
- PEG/PPG-116/66 COPOLYMER
- SILICON DIOXIDE
- Sodium Lauryl Sulfate
- Saccharin Sodium
- Sorbitol
- Water
- Xylitol
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0404-0174 | 0404-0174-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POTASSIUM NITRATE | RU45X2JN0Z | ACTIB |
| SODIUM FLUORIDE | 8ZYQ1474W7 | ACTIM |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | K679OBS311 | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Mica | V8A1AW0880 | IACT |
| Titanium Dioxide | 15FIX9V2JP | IACT |
| PEG/PPG-116/66 COPOLYMER | JP0CK963E0 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| Sodium Lauryl Sulfate | 368GB5141J | IACT |
| Saccharin Sodium | SB8ZUX40TY | IACT |
| Sorbitol | 506T60A25R | IACT |
| Water | 059QF0KO0R | IACT |
| Xylitol | VCQ006KQ1E | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acclean Anti-Cavity Sensitivity Relief | POTASSIUM NITRATE, SODIUM FLUORIDE | Henry Schein, Inc. | d5dc57d9-e62d-4b58-a5df-de4e37238dd7 | 2024-11-14 | Warnings, Adverse reactions | 0404-0174-04 0404-0174 00404017404 170263e7-b523-4250-b542-5bddab28ae43 d5dc57d9-e62d-4b58-a5df-de4e37238dd7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.